Business · 1 sources covering this

Mahindra Group expands Battery-as-a-Service model to entire eSUV portfolio

Mahindra Group on Friday announced the expansion of its Battery-as-a-Service (BaaS) model across its entire eSUV portfolio. Introduced with the launch of the performance-focussed born-electric SUV SPORTEQ, the BaaS model enables customers to finance the vehicle and battery separately through a dual-financing structure. The expanded portfolio now includes all variants of XEV 9S and XEV 9e, besides all variants of BE 6 SPORTEQ, the company said. Under BaaS, customers can pay Rs 11.45 Lakh for the…

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
Mahindra Group expands Battery-as-a-Service model to entire eSUV portfolio
Mahindra Group on Friday announced the expansion of its Battery-as-a-Service (BaaS) model across its entire eSUV portfolio. Introduced with the launch of the performance-focussed born-electric SUV SPORTEQ, the BaaS model enables customers to finance the vehicle and battery separately through a dual-financing structure. The expanded portfolio now includes all variants of XEV 9S and XEV 9e, besides all variants of BE 6 SPORTEQ, the company said. Under BaaS, customers can pay Rs 11.45 Lakh for the…
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/dd65aa94fcdfad03172caf23a6b92f0523ba4461"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Mahindra Group expands Battery-as-a-Service model to entire eSUV portfolio"></iframe>

Mahindra Group expands Battery-as-a-Service model to entire eSUV portfolio

How 1 sources are covering this

Mahindra Group expands Battery-as-a-Service model to entire eSUV portfolio

More from Business

Government to introduce fortnightly sugar allocation

Bernstein flags reading too much into India Inc’s Q1 FY27 performance; maintains Nifty target at 26,000 points

Jio Platforms gets SEBI nod for ‘₹37,700 cr.’ IPO

Tukaram Mundhe-led Maharashtra FDA cancels Cipla unit's drug licence over Reactin Plus irregularities

Reader

Trust & legal

Across the network